期刊文献+

NNMT等分子标记物对脑胶质瘤的诊疗价值

下载PDF
导出
摘要 随着胶质瘤患者治疗技术和理念的更新,仅凭借组织病理学对胶质瘤进行诊断的方法已明显不足。特别是在胶质瘤的分类、胶质瘤的分级判定上受主观影响较大,不能准确反应特定胶质瘤患者的预后及生存期[1];对特定治疗的预测不敏感。近年来,随着高通量技术的发展和人们对分子生物学研究的逐步加深,胶质瘤患者的对标准化方案治疗的效果可借助特定分子病理标记物进行评价。
机构地区 解放军医学院
出处 《航空航天医学杂志》 2016年第5期620-624,共5页 Journal of Aerospace medicine
  • 相关文献

参考文献3

二级参考文献9

  • 1Ito T,Tanaka E,Kadowaki T,et al.An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification.Oncology,2007,73:366-375.
  • 2Xu S,Mou H,Gu L,et al.Screening of the metastasisassociated genes by gene chip in high metastatic human ovarian cancer cell lines.J Genet Genomics,2007,34:581-590.
  • 3Buchholz TA,Davis DW,McConkey DJ,et al.Chemotherapyinduced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.Cancer J,2003,9:33-41.
  • 4Lu M,Xia L,Luo D,et al.Dual effects of glutathione-S-transferase pi on As203 action in prostate cancer cells:enhancement of growth inhibition and inhibition of apoptosis,Oncogene,2004,23:3945-3952.
  • 5Keith WN,Stallard S,Brown R.Expression of mdrl and gst-pi in human breast tumours:comparison to in vitro chemcoensitivity.Br J Cancer,1990,61:712-716.
  • 6Sturm I,Bosanquet AG,Hermann S,et al.Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy.Cell Death Differ,2003,10:477-484.
  • 7Lees E.Cyclin dependent kinase regulation.Curt Opin Cell Biol,1995,7:773-780.
  • 8Crofts F,Taioli E,Trachman J,et al.Functional significance of different human CYPIA1 genotypes.Carcinogenesis,1994,15:2961-2963.
  • 9陈俊,袁亚维,张积仁,周殿元.耐药乳腺癌MCF-7/Adr细胞c-myc的表达上调及与耐药的关系[J].第一军医大学学报,2002,22(2):124-126. 被引量:4

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部